Call for Abstract

2nd International Conference on Central Nervous System Disorders and Therapeutics, will be organized around the theme “Accelerate the Diagnosis, Prevention & Management of CNS Disorders”

CNS 2016 is comprised of 17 tracks and 132 sessions designed to offer comprehensive sessions that address current issues in CNS 2016.

Submit your abstract to any of the mentioned tracks. All related abstracts are accepted.

Register now for the conference by choosing an appropriate package suitable to you.

Central Nervous System may be defined as the system which is made up of the brain and spinal cord. The CNS is vulnerable to various disorders. CNS can be damaged by the following: Trauma, Infections, Degeneration, Structural defects, Tumours, Blood flow disruption, Autoimmune disorders etc.

Approximately 22 million patients suffer from various forms of dementia, two thirds of which are related to Alzheimer’s.  The WHO estimates the number of people suffering from multiple sclerosis worldwide at 2.5 million. As for schizophrenia, 1percent of the world’s population may be at risk.

  • Track 1-1Cerebral edema
  • Track 1-2Functional and structural disorders
  • Track 1-3Fibromyalgia syndrome
  • Track 1-4Arnold–Chiari malformation
  • Track 1-5Bipolar Disorder
  • Track 1-6Neuromyelitis optica
  • Track 1-7Spinal meningitis
  • Track 1-8Hydrocephalus
  • Track 1-9CNS Neoplasia
  • Track 1-10Holoprosencephaly
  • Track 1-11CNS demyelinating disorders
  • Track 1-12Development of Therapeutics for CNS Disorders

Cerebral dysfunction may be focal or global. Focal dysfunction is caused by structural abnormalities and global dysfunction is caused by toxic-metabolic disorders and diffuses inflammation, vasculopathy, major trauma, or disseminated cancer; these diseases affect multiple dimensions of cerebral function.

Every year, an estimated 30,000 people in the United States experience a ruptured cerebral aneurysm and as many as 6percent may have an un-ruptured aneurysm.

  • Track 2-1Cerebral hemorrhage
  • Track 2-2Cerebral Ischemia
  • Track 2-3Cerebral Palsy
  • Track 2-4Cerebral cavernous malformation
  • Track 2-5Canavan Disease
  • Track 2-6Vascular malformation
  • Track 2-7Mini-Strokes
  • Track 2-8Evaluation and diagnosis of cerebrovascular diseases
  • Track 2-9Pathophysiology of cerebrovascular diseases
  • Track 2-10Prevention, Treatment and Therapeutic options

Neuronal Disorders may be defined as the disorders of the Brain, Spine and nerves that connect them. For example: Alzheimer's disease (AD) Epilepsy, Multiple sclerosis etc.

According to World Health Organization report- various types of neurodegenerative disorders affect millions of people around the world, including 25 million that suffer from Parkinson disease and 327 million who experience headaches and migraines.

  • Track 3-1Neuroinflammation diseases
  • Track 3-2Neurodegenerative Disorders
  • Track 3-3Depression
  • Track 3-4Attention Deficit Hyperactivity Disorder
  • Track 3-5Neuroinfections
  • Track 3-6Infantile Neuroaxonal Dystrophy
  • Track 3-7Migraines and Headaches
  • Track 3-8Senility
  • Track 3-9Schizophrenia
  • Track 3-10Neurofibromatosis
  • Track 3-11Werdnig-Hoffmann Disease

Neurosurgery may be defined as the surgical specialty that is concerned with the diagnosis and surgical treatment of the CNS and Peripheral Nervous System.  It is also known as Neurological Surgery. It is performed by a physician called neurosurgeon. Based on nature of disorders or diseases, neurosurgeons provide operative and non-operative care. It helps to treat patients with brain tumour, head and spinal cord injury. Types of Neurosurgery include: I).Endovascular Neurosurgery, II).Oncological Neurosurgery III).Stereotactic Neurosurgery so on.

  • Track 4-1Post-surgical neuralgias
  • Track 4-2Tumour and metastatis
  • Track 4-3Current Neurosurgery methods
  • Track 4-4Vascular malfunctions and surgery
  • Track 4-5Anatomical and functional Neural circuits
  • Track 4-6Neurosurgery Diagnostic Tests
  • Track 4-7Neuropathology

A Neuron communicates its electrical activity to other cells by releasing chemicals at the Junction of the two cells, that process is known as Neurochemical transmission. The chemical substances which transfer an electrical impulse from a nerve cell to its target cell are known as neurotransmitters

  • Track 5-1Dopamine
  • Track 5-2Serotonin
  • Track 5-3Neuropeptides
  • Track 5-4Monoamines
  • Track 5-5Human Synapses
  • Track 5-6Chemical Neurotransmitters
  • Track 5-7Neurotransmission receptors
  • Track 5-8Advances in astrocyte-neuron interactions in health and disease
  • Track 5-9Interneurons: coordinators of neuronal synchrony
  • Track 5-10Drug interaction in various stages in neurotransmitters

Neuro-oncology defines the study of brain and spinal cord neoplasms, many of which are very dangerous and life-threatening. For example: glioma, glioblastoma multiforme, ependymoma, pontine glioma, and brain stem tumours etc.  Most Commonly used treatments in neuro-oncology are Radiotherapy, Chemotherapy, Corticosteroids and Neurosurgical Interventions.

  • Track 6-1Central Nervous System Cancers
  • Track 6-2Tumors
  • Track 6-3Metastatic tumors
  • Track 6-4Pediatric oncology
  • Track 6-5Radiation Oncology
  • Track 6-6Clinical problems in neuro-oncology
  • Track 6-7Neuroimaging and novel technologies
  • Track 6-8Neuropathology
  • Track 6-9Neurotoxicity and neuroprotection

Cognitive neurology is a scientific study of neural mechanism underlying cognition. Cognitive Neurology is concerned with the diagnosis and treatment of diseases that affect memory and other ‘cognitive’ faculties (such as language, perception, planning-ability and social comportment). Cognitive neuroscience is at the intersection of psychology and neuroscience, but it also overlaps with physiological psychology, neuropsychology and cognitive psychology. This combines the theories of cognitive psychology & computational modelling with experimental data about the brain.

  • Track 7-1Neurocognitive
  • Track 7-2Cognition psychology
  • Track 7-3Evolution and Social Cognition
  • Track 7-4Cognitive development
  • Track 7-5Methods of cognitive neurosciencce
  • Track 7-6Neurobehavioral and Cognitive Disorders
  • Track 7-7Cognitive Genomics & behavioural genetics
  • Track 7-8Cognitive rehabilitation therapy
  • Track 7-9Cognitive remediation therapy

The spinal cord refers as the main pathway for information connecting/transferring to the brain and peripheral nervous system. The spinal cord is also known as the large group of nerves which runs through the centre of the spinal cord and carries messages between the brain and the entire body. Spinal disorders may be seen in individuals irrespective of their age-Chiari malformation in infants to spinal stenosis in the elderly. The increase in population with spinal diseases has met with a leap in the advancements in diagnostic and treatment techniques.  The commonly used tools in diagnosing spinal disorders are as follows: X rays, MRI, CT and DEA etc.

  • Track 8-1Spinal Column Anatomy
  • Track 8-2Levels of Injury
  • Track 8-3Syringomyelia
  • Track 8-4Transverse Myelitis
  • Track 8-5Spinal Cord Infarction
  • Track 8-6Spinal Cord Stimulation and Function
  • Track 8-7Spinal Fusion
  • Track 8-8Spinal Diseases
  • Track 8-9Neurospinal Disorders
  • Track 8-10Antithrombotic Therapies in Spine Surgery
  • Track 8-11Diagnosis and treatment of Spinal disorders

Transduction may be defined as the method that converts a sensory signal to an electrical signal to be processed in a specialized area in the brain.

The brain has it specific processing regions that are dedicated to processing the information which has previously passed through the thalamus for both motor and sensory signals. Growth Factor and Cytokine receptors plays very important role in the activation of the signal transduction.

  • Track 9-1Neurophysiology
  • Track 9-2Cytokines
  • Track 9-3Cell Signaling and Signal Transduction Pathways
  • Track 9-4CNS Inflammation

Neurogenesis defines the process by which neurons are generated from neural stem cells and progenitor cells. Many different varieties of excitatory & inhibitory neurons are generated from different kinds of neural stem cells. The molecular and genetic factors influencing genesis of neuron notably include the Notch Signalling pathway, and many genes have been linked to Notch Signalling pathway regulation. It has been found to occur in two brain regions: the subventricular zone and the hippocampus. 

  • Track 10-1Neurogenesis
  • Track 10-2Mechanisms of neurogenesis
  • Track 10-3Neuronal Migration
  • Track 10-4Neurons and Neuronal system
  • Track 10-5Neural Development
  • Track 10-6Adult neurogenesis
  • Track 10-7Neuroplasticity

Neuro-pharmaceutics studies focuses on discovery of therapeutic targets, and then translating those discoveries into drug and therapy development. It is the largest potential growth sector of the pharmaceutical industry. However, this growth is blocked by the problem of the blood-brain barrier.

  • Track 11-1Drug Development
  • Track 11-2Discovery and Development of Therapies
  • Track 11-3Neuropharmacognosy

Clinical Aspects relating to or based on work done with real patients: of or relating to the medical treatment that is given to patients in hospitals, clinics, etc. It involves direct observation of the patient and based on or characterized by observable and diagnosable symptom. For example: Tumours of the Central Nervous System, Clinical Aspects of CNS Cysticercosis, Basic and Clinical Aspects of Malignant Melanoma etc.

  • Track 12-1CNS tuberculosis
  • Track 12-2Neuroimmunological Disorders
  • Track 12-3Genetic testing for CNS disorders
  • Track 12-4Remedies for CNS & Neurological Disorders

Neurology and Neuroscience is the special branch of medical Sciences that deals primarily with the disorders in the CNS. Neurophysiology defined as a union of both neurology and physiology and it studies the functioning of the nervous system.

  • Track 13-1Case studies related to CNS disorders
  • Track 13-2Case studies on neurology
  • Track 13-3Case studies on neuroimmunology
  • Track 13-4Case studies on oncology
  • Track 13-5Case studies on cerebrovascular disorders
  • Track 13-6Case studies on spinal disorders

With an ever increasing average life expectancy, Neurological and CNS Disorders are becoming more prevalent in society. The economic and social costs of Neurological and CNS Disorders to society are huge. Many big pharmaceutical companies have moved away from CNS and Neurology research.

This meeting will give delegates an opportunity to gain additional knowledge and insights into the best practices in clinical trials, as well as addressing the challenges in CNS and Neurology research and by looking at the latest preclinical and clinical studies.

  • Track 14-1Clinical development in MS, PD and AD
  • Track 14-2Current challenges in translational CNS research
  • Track 14-3Improvment of clinical trial development
  • Track 14-4Facilitating and establishing industry and academic partnering
  • Track 14-5Clinical trial safety and evaluation
  • Track 14-6New approaches for the design of clinical trials

The term Biomarker can be defined as a measurable indicator of some biological state or condition. A biomarker can also be known as a biological biomarker.

CNS 2016 conference focuses on the development of CNS biomarkers for drugs and diagnostics from Cerebrospinal fluid and Blood, as well as imaging approaches. Scientific data, updates and case studies in neurological and neurodegenerative diseases will be presented on disease areas such as Alzheimer's and Parkinson's.

  • Track 15-1Supporting CNS drug development using biomarkers
  • Track 15-2Cerebral CSF flow studies
  • Track 15-3Cerebrospinal fluid biomarkers
  • Track 15-4Neuroimaging enrichment biomarkers for CNS diseases
  • Track 15-5Biomarker Challenges in Rare Diseases
  • Track 15-6Technology case studies for CNS
  • Track 15-7Biomarkers implication in clinical trials

The neuroscience perspective relates to the way that people act in terms of how they came to be. It deals with the scientific study of the nervous system and recognized as the branch of biology. On the other hand, neurology perspective deals with the branch of medicine dealing with the disorders of nervous system, diagnosis and treatment of all kind of diseases in the central nervous system and peripheral nervous system.

  • Track 16-1Cognitive Neuroscience
  • Track 16-2Clinical neurophysiology
  • Track 16-3Neuroimmunology
  • Track 16-4Neurorehabilitation
  • Track 16-5Neurological Nursing

The term “Drug metabolism” refers the metabolic breakdown of drugs by living organisms, usually through specialized enzymatic systems.  It is divided into three phases: I). Enzymes such as cytochrome P450 oxidases introduce reactive or polar groups into xenobiotic II). Modified compounds are then conjugated to polar compounds III). Conjugated xenobiotic may be further processed, before being recognised by efflux transporters and pumped out of cells.

  • Track 17-1Anti-neurodegenerative drug discovery
  • Track 17-2Ion channels, transporters and neurotransmitter receptors
  • Track 17-3Neural stem cells and gene or cell therapy
  • Track 17-4Neurotransmitters, neuromodulators, and neuroreceptors
  • Track 17-5Centrally acting analgesics
  • Track 17-6Blood brain barrier (BBB)
  • Track 17-7Metabolism mediated drug-drug interactions
  • Track 17-8Enzyme kinetics
  • Track 17-9Role of drug metabolism in drug development
  • Track 17-10Nanoparticles as drug carriers
  • Track 17-11Neurological Drug Targets